Ocular Therapeutix Names Patricia Kitchen as Chief Operations Officer

By

Patricia Kitchen

BEDFORD, Mass.—Biopharmaceutical company Ocular Therapeutix has appointed Patricia Kitchen as chief operations officer. Kitchen brings nearly 25 years of biotechnology and pharmaceutical experience, including roles managing global operations and manufacturing relating to complex product development, technology transfer, supply chain management, and process-scale up and validation. Prior to joining Ocular, she held a number of senior management positions at Mundipharma, including global director of technical operations (ex-U.S.) where she was responsible for leading the transformation of manufacturing operations, supply chain, technical services, and other technical development teams across Mundipharma’s global markets and manufacturing suppliers.

Prior to her work at Mundipharma, Kitchen occupied executive roles in operations and manufacturing at Teva Pharmaceuticals and Actavis, Inc. (formerly Watson Pharmaceuticals).

Kitchen was an adjunct professor in biotechnology and currently participates on several FDA development task forces focused on patient drug development, biotechnology development and transdermal product development.